Spotlight at Guidelines on Continuous Glucose Monitoring in Type 2 Diabetes

Show notes

Watch the full video on YouTube. Continuous glucose monitoring (CGM) is becoming an increasingly important part of diabetes care, but how should it be used in people living with type 2 diabetes?

In this episode, Dame Melanie Davies and Prof. Amanda Adler discuss the development of a new EASD clinical guideline on CGM in type 2 diabetes. They explain how guideline topics are selected, the rigorous process of reviewing evidence, and why patient perspectives are essential to developing meaningful recommendations.

The discussion explores outcomes beyond HbA1c, including quality of life, confidence in self-management, behaviour change, and broader health impacts. The speakers also consider how future recommendations could influence clinical practice, healthcare policy, and access to diabetes technology.

Explore the latest EASD Annual Meeting presentations and learn more about our featured speakers:

  1. Dame Melanie Davies - University of Leicester, diabetes clinician-scientist and co-chair of the EASD CGM Guideline Group

  2. Prof. Amanda Adler - University of Oxford, diabetologist, health services researcher, and co-chair of the EASD CGM Guideline Group

For more content from our previous episodes, visit our podcast archive.

New comment

Your name or nickname, will be shown publicly
At least 10 characters long
By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.